Important Notice Before You Proceed
Dosing Protocols · Regulatory Context
Regulatory Status of Peptide Supplements
Many of the peptides referenced in these protocols — outside of the Compounded Peptides section — are not currently approved for prescription or compounding under existing FDA guidelines. Physicians cannot specifically prescribe these products at this time. This information is provided solely as a clinical educational reference.
Physician Discount Store
As a registered physician partner, you have access to our private discount store — purchase Rx and non-Rx products at 40% off for in-office dispensing or direct patient distribution.
Get accessPatient Referral Program
Refer your patients to CareViaConnect — a dedicated platform where patients can access vetted peptide products. Enroll in our physician referral program.
Physician Referral ProgramFor licensed prescribers only · Not for patient distribution
Peptide Dosing Frameworks
AMCT™-optimized dosing protocols for single and combination peptide therapy.
GLP-1 Receptor Agonist Dosing
Semaglutide & Tirzepatide — AMCT™-enabled oral capsule. 503a compounded. Prescription required.
GH Optimization Stack
Adults 35+ with fatigue, poor recovery, or body composition concerns
Metabolic & Body Composition
Patients with obesity, insulin resistance, or metabolic syndrome
Cognitive Clarity & Neuroprotection
Patients with brain fog, early cognitive decline, high-stress professionals
Comprehensive Recovery
Post-surgical patients, athletes, chronic musculoskeletal injury
Longevity & Immune Resilience
Patients focused on healthspan, immunosenescence, or post-infection recovery
Important Clinical Notice
All frameworks are educational references only for licensed prescribers. No claims of bioequivalence or therapeutic equivalence are made. All prescribing decisions remain with the treating clinician. Dosing should be individualized based on patient history, labs, and clinical judgment.